These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19195830)

  • 1. The cost-effectiveness of routine follow-up after primary total hip arthroplasty.
    Bolz KM; Crawford RW; Donnelly B; Whitehouse SL; Graves N
    J Arthroplasty; 2010 Feb; 25(2):191-6. PubMed ID: 19195830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and cost-effectiveness 1 year after total hip arthroplasty.
    Lavernia CJ; Alcerro JC
    J Arthroplasty; 2011 Aug; 26(5):705-9. PubMed ID: 20870386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
    Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
    Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs.
    Räsänen P; Paavolainen P; Sintonen H; Koivisto AM; Blom M; Ryynänen OP; Roine RP
    Acta Orthop; 2007 Feb; 78(1):108-15. PubMed ID: 17453401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
    Suresh GK; Clark RE
    Pediatrics; 2004 Oct; 114(4):917-24. PubMed ID: 15466085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
    Rampersaud YR; Ravi B; Lewis SJ; Stas V; Barron R; Davey R; Mahomed N
    Spine J; 2008; 8(2):296-304. PubMed ID: 17669690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
    Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic outcomes from patients' perspective and health-related quality of life after total hip arthroplasty.
    Montin L; Suominen T; Katajisto J; Lepistö J; Leino-Kilpi H
    Scand J Caring Sci; 2009 Mar; 23(1):11-20. PubMed ID: 19250450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life assessment one year after total hip or knee arthroplasty].
    Mainard D; Guillemin F; Cuny C; Mejat-Adler E; Galois L; Delagoutte J
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Sep; 86(5):464-73. PubMed ID: 10970970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness and quality of life in knee arthroplasty.
    Lavernia CJ; Guzman JF; Gachupin-Garcia A
    Clin Orthop Relat Res; 1997 Dec; (345):134-9. PubMed ID: 9418630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of C-leg compared with non-microprocessor-controlled knees: a modeling approach.
    Brodtkorb TH; Henriksson M; Johannesen-Munk K; Thidell F
    Arch Phys Med Rehabil; 2008 Jan; 89(1):24-30. PubMed ID: 18164326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal follow-up strategies after aorto-iliac prosthetic reconstruction: a decision analysis and cost-effectiveness analysis.
    Post PN; Kievit J; van Bockel JH
    Eur J Vasc Endovasc Surg; 2004 Sep; 28(3):287-95. PubMed ID: 15288633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total joint replacement: a cost-effective procedure for the 1990s.
    Hirsch HS
    Med Health R I; 1998 May; 81(5):162-4. PubMed ID: 9617092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.